RECENT POSTS
FAST MONEY FEATURES
FAST MONEY POLLGet in the post game. Respond to our "Question of the Day" right now.
FULL SHOWSMissed an episode of Fast Money? Watch the lastest show here.
TRADE SCHOOLGrab a pencil because school is in session and the Fast Money traders are teaching class.
FAST MONEY PODCASTSDownload Fast Money onto your MP3 Player.
FAST MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
SHOP FOR FAST MONEY MERCHANDISEGet your game on with Fast Money gear.
FAST MONEY PHOTOS!Check out our scrapbook. These "pix" are guaranteed winners.
NEWSLETTERSign up and receive a recap email every Friday after the show!
FAST MONEY MOBILE ALERTSGet advanced information about the next Fast Money.
Text Size 
 |
Which biopharma firm could be just what the doctor ordered to remedy an ailing portfolio?
Guy Adami says it's Geron [GERN
Loading...
()
] !
In the worldwide race to develop stem cell therapies, Geron is a leader. According to the firm's website, Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes.
Here are some more particulars:
| ||
Geron (GERN)
-Based in Menlo Park, CA
-Sector: Healthcare
-Industry: Biotechnology & Drugs
-Market Cap: $467.5 million
-52 Week Low $1.95
-52 Week High $8.50
-Up about 13% since the beginning of '09
What makes Geron a rising star?
Essentially, it’s an intellectual property play, says Adami. These guys have something like 300 patents. Also there’s decent short interest; so in the near term I think you could see a short-covering rally.
However, if you go in for the long term, it's important to remember that biotechs are a bit of a gamble. Just know that it could go to zero, or it could go to $10.
- Halftime Report: Dubai - First Ripple Of Larger Crisis?
- Your First Move For Friday November 27th
- Web Extra: Private Equity, Conviction Buy?
- Pops & Drops: Abercrombie & Fitch, Nucor...
- Giving Thanks: Seymour
- Your Questions About... Alcoa & The Dollar
- Best Wishes Regis
- Gartman's Annual Rules For Trading
- Chartology: December Outlook
- Holiday Toy Trades
______________________________________________________
Got something to say? Send us an e-mail at and your comment might be posted on the Rapid Recap! If you'd prefer to make a comment but not have it published on our website send your message to .
Trader disclosure: On May 4th, 2009, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Adami Owns (AGU), (BTU), (C), (GS), (INTC), (MSFT), (NUE); Seymour Owns (AAPL), (BAC), (EEM), (FXI), (SBUX); Seymour' Firm Owns (PBR), (MBT); Seymour Is Short (X); Najarian Owns (BX) Call Spread; Najarian Owns (CROX) Call Spread; Najarian Owns (CX) Calls; Najarina Owns (FIG; Najarian Owns (INTC) Call Spread; Najarian Owns (MS) & (MS) Calls; Najarian Owns (PALM) & (PALM) Calls; Najarian Owns (VAR) Call Spread; Najarian Owns (XHB) Cal Spread; Najarian Owns (XLB) Call Spread; Finerman's Firm Owns (BAC) Preferred; Finerman's Firm Owns (C) Preferred; Finerman's Firm Owns(MSFT) & (MSFT) Put Spread; Finerman's Firm Owns (AXP), (MA), (PBR), (RIG), (UNH), (TBT); Finermans Firm Is Short (IJR), (MDY), (SPY), (IWM), (USO)
Data is a real-time snapshot *Data is delayed at least 15 minutes